2,551
Views
23
CrossRef citations to date
0
Altmetric
Case Report

Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example

, , &
Pages 166-173 | Received 30 Nov 2018, Accepted 21 Feb 2019, Published online: 19 Mar 2019

References

  • American Psychological Association. 2017. Clinical practice guidelines for the treatment of PTSD. https://www.apa.org/ptsd-guideline/.
  • Bradley, R., J. Greene, E. Russ, L. Dutra, and D. Westen. 2005. A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry 162 (2):214–27. doi:10.1176/appi.ajp.162.2.214.
  • Carhart-Harris, R. L., K. Murphy, R. Leech, D. Erritzoe, M. B. Wall, B. Ferguson, L. T. J. Williams, L. Roseman, S. Brugger, I. De Meer, et al. 2015. The effects of acutely administered 3, 4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level–Dependent resting state functional connectivity. Biological Psychiatry 78 (8):554–62. doi:10.1016/j.biopsych.2013.12.015.
  • Chard, K. M., E. G. Ricksecker, E. T. Healy, B. E. Karlin, and P. A. Resick. 2012. Dissemination and experience with cognitive processing therapy. Journal of Rehabilitation Research & Development 49 (5). doi:10.1682/JRRD.2011.10.0198.
  • de la Torre, R., M. Farre, P. N. Roset, C. Hernández López, M. Mas, J. Ortuno, E. Menoyo, N. Pizarro, J. Segura, and J. Cami. 2000. Pharmacology of MDMA in humans. Annals of the New York Academy of Sciences 914 (1):225–37.
  • Dumont, G. J. H., F. C. G. J. Sweep, R. Van der Steen, R. Hermsen, A. R. T. Donders, D. J. Touw, J. M. A. van Gerven, J. K. Buitelaar, and R. J. Verkes. 2009. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Social Neuroscience 4 (4):359–66. doi:10.1080/17470910802649470.
  • Emanuele, E., M. Arra, and S. Pesenti. 2006. Vasopressin and oxytocin as neurohormonal mediators of MDMA (ecstasy) sociosexual behavioural effects. Medical Hypotheses 67 (5):1250–51. doi:10.1016/j.mehy.2006.05.021.
  • Feduccia, A. A., and M. C. Mithoefer. 2018. MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? Progress in Neuro-Psychopharmacology and BiologicalPsychiatry 84 (A): 221-28. doi:10.1016/j.pnpbp.2018.03.003.
  • First, M. B., J. B. W. Williams, R. S. Karg, and R. L. Spitzer. 2015. Structured clinical interview for DSM-5—Research version (SCID-5 for DSM-5, research version; SCID-5-RV). Arlington, VA: American Psychiatric Association.
  • Foa, E. B., E. A. Hembree, and B. O. Rothbaum. 2007. Prolonged exposure therapy for PTSD: Therapist guide. New York, NY: Oxford University Press.
  • Foa, E. B., E. A. Hembree, S. P. Cahill, S. A. M. Rauch, D. S. Riggs, N. C. Feeny, and E. Yadin. 2005. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: Outcome at academic and community clinics. Journal of Consulting and Clinical Psychology 73 (5):953–64. doi:10.1037/0022-006X.73.5.953.
  • Foa, E. B., S. J. Gillihan, and R. A. Bryant. 2013. Challenges and successes in dissemination of evidence-based treatments for posttraumatic stress: Lessons learned from prolonged exposure therapy for PTSD. Psychological Science in the Public Interest 14 (2):65–111. doi:10.1177/1529100612468841.
  • Fredman, S. J., A. Macdonald, C. M. Monson, G. K. Rhoades, and K. A. Dondanville, and The Consortium to Alleviate PTSD. 2018. Open trial of cognitive-behavioral conjoint therapy for PTSD delivered in an intensive weekend retreat for military and veteran couples. Presentation given at the International Society of Traumatic Stress Studies, Washington, DC.
  • Funk, J. L., and R. D. Rogge. 2007. Testing the ruler with item response theory: Increasing precision of measurement for relationship satisfaction with the Couples Satisfaction Index. Journal of Family Psychology 21 (4):572–83. doi:10.1037/0893-3200.21.4.572.
  • Gamma, A., A. Buck, T. Berthold, D. Hell, and F. X. Vollenweider. 2000. 3, 4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215O]-PET in healthy humans. Neuropsychopharmacology 23 (4):388–95. doi:10.1016/S0893-133X(00)00130-5.
  • Green, A. R., A. O. Mechan, J. M. Elliott, E. OShea, and M. I. Colado. 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacological Reviews 55 (3):463–508. doi:10.1124/pr.55.3.3.
  • Greer, G. 1985. Using MDMA in psychotherapy. Advances 2 (2):57–59.
  • Greer, G., and R. Tolbert. 1986. Subjective reports of the effects of MDMA in a clinical setting. Journal of Psychoactive Drugs 30:371–79. doi:10.1080/02791072.1998.10399713.
  • Grof, S. 2001. LSD psychotherapy. Sarasota, FL: Multidisciplinary Association for Psychedelic Studies.
  • International Society of Traumatic Stress Studies. 2018. ISTSS prevention and treatment guidelines. http://www.istss.org/treating-trauma/new-istss-guidelines.aspx.
  • Karlin, B. E., J. I. Ruzek, K. M. Chard, A. Eftekhari, C. M. Monson, E. A. Hembree, P. A. Resick, and E. B. Foa. 2010. Dissemination of evidence‐based psychological treatments for posttraumatic stress disorder in the Veterans Health Administration. Journal of Traumatic Stress 23 (6):663–73. doi:10.1002/jts.20588.
  • Kuypers, K. P. C., R. de la Torre, M. Farre, S. Yubero-Lahoz, I. Dziobek, W. Van den Bos, and J. G. Ramaekers. 2014. No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation. PLoS One 9 (6):e100719. doi:10.1371/journal.pone.0100719.
  • Lambert, J. E., R. Engh, A. Hasbun, and J. Holzer. 2012. Impact of posttraumatic stress disorder on the relationship quality and psychological distress of intimate partners: A meta-analytic review. Journal of Family Psychology 26 (5):729–37. doi:10.1037/a0029341.
  • Meis, L. A., K. W. Schaaf, C. R. Erbes, M. A. Polusny, L. R. Miron, T. M. Schmitz, and S. M. Nugent. 2013. Interest in partner-involved services among veterans seeking mental health care from a VA PTSD clinic. Psychological Trauma: Theory, Research, Practice, and Policy 5 (4):334–42. doi:10.1037/a0028366.
  • Mithoefer, M., A. Mithoefer, L. Jerome, J. Ruse, R. Doblin, M. Ot’alora, and E. Sola. 2018a. A manual for MDMA-assisted psychotherapy in the treatment of PTSD. 9th ed. Santa Cruz, California: MAPS. https://maps.org/research/mdma/mdma-research-timeline/4887-a-manual-for-mdma-assisted-psychotherapy-in-the-treatment-of-ptsd.
  • Mithoefer, M. C., A. T. Mithoefer, A. A. Feduccia, L. Jerome, M. Wagner, J. Wymer, J. Holland, S. Hamilton, B. Yazar-Klosinski, A. Emerson, et al. 2018b. 3,4 methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: A randomized, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry 5 (6):486–97. doi:10.1016/S2215-0366(18)30135-4.
  • Mithoefer, M. C., M. T. Wagner, A. T. Mithoefer, L. Jerome, and R. Doblin. 2011. The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology 25 (4):439–52. doi:10.1177/0269881110378371.
  • Mithoefer, M. C., M. T. Wagner, A. T. Mithoefer, L. Jerome, S. F. Martin, B. Yazar-Klosinski, Y. Michel, T. D. Brewerton, and R. Doblin. 2013. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3, 4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology 27 (1):28–39. doi:10.1177/0269881112456611.
  • Monson, C. M., S. J. Fredman, and R. Dekel. 2010. Posttraumatic stress disorder in an interpersonal context. In Interpersonal processes in the anxiety disorders: Implications for understanding psychopathology and treatment, ed. J. G. Beck, 179–208. Washington, DC, US: American Psychological Association.
  • Monson, C. M., P. P. Schnurr, P. A. Resick, M. J. Friedman, Y. Young-Xu, and S. P. Stevens. 2006. Cognitive processing therapy for veterans with military-related posttraumatic stress disorder. Journal of Consulting and Clinical Psychology 74 (5):898. doi:10.1037/0022-006X.74.5.898.
  • Monson, C. M., P. P. Schnurr, S. P. Stevens, and K. A. Guthrie. 2004. Cognitive–behavioral couple’s treatment for posttraumatic stress disorder: Initial findings. Journal of Traumatic Stress 17 (4):341–44. doi:10.1023/B:JOTS.0000038483.69570.5b.
  • Monson, C. M., and S. J. Fredman. 2012. Cognitive-behavioral conjoint therapy for PTSD. New York, NY: Guilford Press.
  • Monson, C. M., N. Shields, M. K. Suvak, J. E. M. Lane, P. Shnaider, M. S. H. Landy, A. C. Wagner, I. Sijercic, T. Masina, S. G. Wanklyn, et al. 2018. A randomized controlled effectiveness trial of training strategies in cognitive processing therapy for posttraumatic stress disorder: Impact on patient outcomes. Behaviour Research and Therapy 110:31–40. doi:10.1016/j.brat.2018.08.007.
  • Morland, L., K. Grubbs, A. Macdonald, C. M. Monson, B. Buzzella, E. Wrape, I. Wickramasinghe, S. Wells and M. A. Mackintosh. 2018. Abbreviated cognitive behavioral couples therapy into the home: A scalable model for couples with PTSD. Presentation given at the International Society of Traumatic Stress Studies, Washington, DC.
  • Passie, T., and U. Benzenhofer. 2016. The history of MDMA as an underground drug in the United States, 1960–1979. Journal of Psychoactive Drugs 48 (2):67–75. doi:10.1080/02791072.2015.1128580.
  • Passie, T. 2018. The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law 4:1–19. doi:10.1177/2050324518767442.
  • Resick, P. A., C. M. Monson, and K. M. Chard. 2016. Cognitive processing therapy for PTSD: A comprehensive manual. New York, NY: Guilford Press.
  • Resick, P. A., P. Nishith, T. L. Weaver, M. C. Astin, and C. A. Feuer. 2002. A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. Journal of Consulting and Clinical Psychology 70 (4):867. doi:10.1037/0022-006X.70.4.867.
  • Riedlinger, T. J., and J. E. Riedlinger. 1994. Psychedelic and entactogenic drugs in the treatment of depression. Journal Of Psychoactive Drugs 26 (1):41–55. doi: 10.1080/02791072.1994.10472600.
  • Shapiro, F. 2001. Eye movement desensitization and reprocessing: Basic principles, protocols and procedures. 2nd ed. New York, NY: Guilford Press.
  • Shnaider, P., N. D. Pukay‐Martin, S. J. Fredman, A. Macdonald, and C. M. Monson. 2014. Effects of cognitive–behavioral conjoint therapy for PTSD on partners’ psychological functioning. Journal of Traumatic Stress 27 (2):129–36. doi:10.1002/jts.21893.
  • Stecker, T., B. Shiner, B. V. Watts, M. Jones, and K. R. Conner. 2013. Treatment-seeking barriers for veterans of the Iraq and Afghanistan conflicts who screen positive for PTSD. Psychiatric Services 64 (3):280–83. doi:10.1176/appi.ps.001372012.
  • Watts, B. V., P. P. Schnurr, L. Mayo, Y. Young-Xu, W. B. Weeks, and M. J. Friedman. 2013. Meta-analysis of the efficacy of treatments. Journal of Clinical Psychiatry 74 (6):e541–e550. doi:10.4088/JCP.12r08225.
  • Weathers, F. W., B. T. Litz, T. M. Keane, P. A. Palmieri, B. P. Marx, and P. P. Schnurr. 2013b. The PTSD checklist for DSM-5 (PCL-5).  Washington, DC: U.S. Department of Veterans Affairs. Scale available from the National Center for PTSD at www.ptsd.va.gov.
  • Weathers, F. W., D. D. Blake, P. P. Schnurr, D. G. Kaloupek, B. P. Marx, and T. M. Keane. 2013a. The clinician-administered PTSD scale for DSM-5 (CAPS-5). Washington, DC: U.S. Department of Veterans Affairs. Interview available from the National Center for PTSD at www.ptsd.va.gov.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.